| Literature DB >> 31827881 |
Jihyo Park1, Haeram Moon1, Seonki Hong1.
Abstract
BACKGROUND: Melanins are a group of biopigments in microorganisms that generate a wide range of colorants. Due to their multifunctionality, including ultraviolet protection, radical scavenging, and photothermal conversion, in addition to their intrinsic biocompatibility, natural melanins and synthetic melanin-like nanomaterials have been suggested as novel nano-bio platforms in biomedical applications. MAIN BODY: Recent approaches in the synthesis of melanin-like nanomaterials and their biomedical applications have briefly been reviewed. Melanin-like nanomaterials have been suggested as endogenous chromophores for photoacoustic imaging and radical scavengers for the treatment of inflammatory diseases. The photothermal conversion ability of these materials under near-infrared irradiation allows hyperthermia-mediated cancer treatments, and their intrinsic fluorescence can be an indicator in biosensing applications. Furthermore, catechol-rich melanin and melanin-like nanomaterials possess a versatile affinity for various functional organic and inorganic additives, allowing the design of multifunctional hybrid nanomaterials that expand their range of applications in bioimaging, therapy, theranostics, and biosensing.Entities:
Keywords: Bioimaging; Biosensing; Drug delivery; Melanin; Polydopamine; Theranostics
Year: 2019 PMID: 31827881 PMCID: PMC6889561 DOI: 10.1186/s40824-019-0175-9
Source DB: PubMed Journal: Biomater Res ISSN: 1226-4601
A summary of melanin-like nanomaterials synthesized for biomedical applications
| Biomedical applications | Template | Size | Functional additives | Ref | |
|---|---|---|---|---|---|
| Therapy | ROS scavenger | pDA NP | 80 nm | – | [ |
| 160 nm | w/ and w/o Cu2+ | [ | |||
| Photodynamic therapy | pDA/PEG coating on CaCO3 | 40 nm | Photosensitizer: chlorin e6 | [ | |
| Photothermal therapy | pDA NP | 160 nm | – | [ | |
| PEGylated pDA NP | 78 nm | Anticancer drug: doxorubicin, 7-ethyl-10-hydroxycamptothecin | [ | ||
| Drug delivery system | pDA NP | 75–400 nm | Anticancer drug: camptothecin | [ | |
| PEGylated pDA NP | 28 nm | Ligand: triphenylphosphonium Anticancer drug: doxorubicin | [ | ||
| Polyethylenimine-decorated pDA NP | 60–80 nm | Therapeutics: plasmid DNA | [ | ||
| Poly (methacrylic acid) -coated pDA capsule | 300 nm | Anticancer drug: doxorubicin | [ | ||
| pDA coating on insulin NP | 50, 71, 84 nm (coating) | – | [ | ||
| pDA/PEG coating on mesoporous silica NP | 193.08 nm | Ligand: folic acidAnticancer drug: doxorubicin | [ | ||
| Bioimaging and theranostics | Photoacoustic Imaging | Ethylenediamine/PEG-coated pDA NP | 130 nm | – | [ |
| pDA-coated AuNP | 150 nm | – | [ | ||
| PDA-coated Fe3O4 NP | 15 nm | 64Cu | [ | ||
| Melanin NP | 42.5 ± 2.1 nm | Targeting moiety: poly-L-lysine | [ | ||
| Magnetic resonance imaging | pDA NP | 51, 119, 188 nm | Cu (II) | [ | |
| PEGylated pDA NP | 70–300 nm | Mn (II) | [ | ||
| 25–43 nm | Fe (III) | [ | |||
| PEGylated Melanin NP | 13 nm | Gd (III), Cu (II) | [ | ||
| Biosensing | Fluorescent pDA | pDA with ethylenediamine NP | Tens of nm | – | [ |
| pDA NP reduced by NaBH4 | 34.83 nm | – | [ | ||
| Fluorescence quencher | Mesoporous pDA NP | 70 nm | Fluorescein amidites (FAM)-labeled DNA probe | [ | |
| pDA-coated upconversion NP | 5 nm (coating) | Cy3-aptamer | [ | ||